-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on TransMedics Group, Raises Price Target to $110

Benzinga·11/06/2026 20:19:09
Listen to the news
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and raises the price target from $106 to $110.